ATE555813T1 - Bildgebung von infektionen mit an thymidinkinase bindenden verbindungen - Google Patents

Bildgebung von infektionen mit an thymidinkinase bindenden verbindungen

Info

Publication number
ATE555813T1
ATE555813T1 AT05788432T AT05788432T ATE555813T1 AT E555813 T1 ATE555813 T1 AT E555813T1 AT 05788432 T AT05788432 T AT 05788432T AT 05788432 T AT05788432 T AT 05788432T AT E555813 T1 ATE555813 T1 AT E555813T1
Authority
AT
Austria
Prior art keywords
thymidiine
kinase
subject
compounds binding
imaging
Prior art date
Application number
AT05788432T
Other languages
English (en)
Inventor
Martin Pomper
Chetan Bettegowda
Catherine Foss
Shibin Zhou
Kenneth Kinzler
Bert Vogelstein
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Application granted granted Critical
Publication of ATE555813T1 publication Critical patent/ATE555813T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1231—Aerosols or breath tests, e.g. administration of gasses, emanators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of Radiation (AREA)
  • Nuclear Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05788432T 2004-06-18 2005-06-20 Bildgebung von infektionen mit an thymidinkinase bindenden verbindungen ATE555813T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58122204P 2004-06-18 2004-06-18
PCT/US2005/021888 WO2006002142A2 (en) 2004-06-18 2005-06-20 Imaging infection with compounds that bind to thymidine kinase

Publications (1)

Publication Number Publication Date
ATE555813T1 true ATE555813T1 (de) 2012-05-15

Family

ID=35385588

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05788432T ATE555813T1 (de) 2004-06-18 2005-06-20 Bildgebung von infektionen mit an thymidinkinase bindenden verbindungen

Country Status (10)

Country Link
US (2) US8273326B2 (de)
EP (2) EP2283871A1 (de)
JP (2) JP5324782B2 (de)
CN (1) CN101068576B (de)
AT (1) ATE555813T1 (de)
AU (1) AU2005258042B2 (de)
CA (1) CA2571346C (de)
DK (1) DK1768704T3 (de)
ES (1) ES2387094T3 (de)
WO (1) WO2006002142A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100112561A1 (en) * 2006-08-25 2010-05-06 Stefan Lutz Fluorescent nucleoside analogues
CN101730538B (zh) * 2007-04-10 2015-04-29 约翰·霍普金斯大学 与病毒相关肿瘤的成像和疗法
US20130323167A1 (en) * 2010-10-21 2013-12-05 The Johns Hopkins University Detecting and treating solid tumors through selective disruption of tumor vasculature
WO2013048952A1 (en) * 2011-09-28 2013-04-04 Biomed Valley Discoveries, Inc. Methods and compositions for detecting infections
KR101456235B1 (ko) * 2013-07-10 2014-11-04 한국원자력의학원 방사성 동위원소를 포함하는 화합물을 이용한 세균 감염 검출 방법
US20170350898A1 (en) * 2014-11-06 2017-12-07 Veterinary Diagnostics Institute, Inc. Method and apparatus for detecting vector-borne diseases in humans
CN114114295B (zh) 2018-06-15 2025-06-06 图达通智能美国有限公司 用于聚焦感兴趣的范围的lidar系统和方法
ES2983670T3 (es) * 2019-05-06 2024-10-24 Arocell Ab Detección y clasificación de infecciones respiratorias

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5103098A (en) 1989-11-09 1992-04-07 Board Of Regents, The University Of Texas System High resolution gamma ray detectors for positron emission tomography (pet) and single photon emission computed tomography (spect)
US5272343A (en) 1992-07-27 1993-12-21 General Electric Company Sorter for coincidence timing calibration in a PET scanner
JPH06347555A (ja) 1993-06-10 1994-12-22 Hamamatsu Photonics Kk ポジトロンイメージング装置
US5608221A (en) 1995-06-09 1997-03-04 Adac Laboratories Multi-head nuclear medicine camera for dual SPECT and PET imaging with monuniform attenuation correction
US5879661A (en) * 1995-08-23 1999-03-09 University Advanced Bio-Imaging Associates Imaging agents and methods for the preparation and use thereof
US6331287B1 (en) * 1995-08-23 2001-12-18 University Advanced Bio-Imaging Associates 2′-deoxy-2′-fluoro-d-arabinofuranosyl pyrimidine nucleoside
SE9602594D0 (sv) 1996-07-01 1996-07-01 Stefan Nilsson Förfarande och anordning vid datortomografi
GB9707695D0 (en) * 1996-08-07 1997-06-04 Hoffmann La Roche Tricyclic dione derivatives
US5841140A (en) 1997-01-08 1998-11-24 Smv America, Inc. Gamma camera for pet and spect studies
US5900636A (en) 1997-05-30 1999-05-04 Adac Laboratories Dual-mode gamma camera system utilizing single-photon transmission scanning for attenuation correction of PET data
US6562319B2 (en) * 2001-03-12 2003-05-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
US6331278B1 (en) * 2001-03-13 2001-12-18 Herbert W. Copelan Self-contained double handhold for preventing false urine specimens

Also Published As

Publication number Publication date
EP1768704B1 (de) 2012-05-02
WO2006002142A2 (en) 2006-01-05
US20130064767A1 (en) 2013-03-14
EP2283871A1 (de) 2011-02-16
US8273326B2 (en) 2012-09-25
US8691186B2 (en) 2014-04-08
US20090010844A1 (en) 2009-01-08
AU2005258042A1 (en) 2006-01-05
CA2571346C (en) 2014-08-12
JP2008503499A (ja) 2008-02-07
CN101068576A (zh) 2007-11-07
DK1768704T3 (da) 2012-07-02
JP2013049673A (ja) 2013-03-14
EP1768704B9 (de) 2013-01-02
AU2005258042B2 (en) 2010-11-11
WO2006002142A3 (en) 2006-05-04
JP5324782B2 (ja) 2013-10-23
ES2387094T3 (es) 2012-09-13
EP1768704A2 (de) 2007-04-04
CN101068576B (zh) 2016-05-04
CA2571346A1 (en) 2006-01-05

Similar Documents

Publication Publication Date Title
ES2487846T3 (es) Anticuerpos anti-hepcindina y métodos de uso
MA29369B1 (fr) Dosage fixe d'anticorps anti-her
ATE516298T1 (de) Erkennung von primären infektionen mit krankheitserregern
BRPI0605921A2 (pt) compostos orgánicos
EA201290089A1 (ru) Химические соединения
MX348859B (es) Agentes de contraste para formacion de imagenes por perfusion miocardial.
MA32787B1 (fr) Peptides antiviraux therapeutiques
CR8698A (es) Anticuerpos monoclonales al factor de crecimiento de hepatocito
EP2211709A4 (de) Mit binauralen tönen erweitertes biofeedbacksystem
EA200900064A1 (ru) Ингибирование агрегации альфа-синуклеина
EA200971096A1 (ru) Терапевтические композиции и их применение
NO20065048L (no) Kontrastmidler for myocardial perfusjonsbilleddannelse.
DK2109623T3 (da) Cancerbehandling med anti-IL-1-antistoffer
DE602005021644D1 (de) Verfahren und reagentien zur diagnose von hantavirusinfektionen
ATE555813T1 (de) Bildgebung von infektionen mit an thymidinkinase bindenden verbindungen
EA201270502A1 (ru) Документ
EA200700202A1 (ru) Гетероарильные соединения в качестве бетамиметиков для лечения заболеваний дыхательных путей
WO2009137677A3 (en) Reagents, methods, and systems for detecting methicillin-resistant staphylococcus
GT200600030A (es) 2-fenil-indoles como antagonistas del receptor de la prostaglandina d2
ATE426174T1 (de) Verfahren zum nachweis der amyloid-beta oligomere in kírperflussigkeiten
WO2011093675A3 (ko) 혈액으로부터 직접 폐암 진단 및 폐암의 서브타입 진단이 가능한 마커를 선별하는 시스템 생물학적 방법 및 이로부터 선별된 혈액으로부터 직접 폐암 진단 및 폐암 서브타입 진단이 가능한 마커
EA201170828A1 (ru) Конденсированные гетероциклические производные оксадиазола, подходящие для лечения рассеянного склероза
WO2009146210A3 (en) New human parvovirus: bocavirus
WO2007030391A3 (en) Method for diagnosing infections
CL2007003659A1 (es) Kit de deteccion de microorganismos patogenos mediante pruebas de aliento.